| Literature DB >> 33776442 |
Xiang-Yu Wei1, Hui Chen1, Cui Guo1, Wen-Li Tan1, Song-Hua Zhan1.
Abstract
OBJECTION: This study was a primary study to evaluate the instant and sustained effect of electroacupuncture (EA) at GV20 (Baihui) in postgraduate students with mild depression by using a special flexible head coil.Entities:
Keywords: acupuncture; default mode network; DMN; depression; functional magnetic resonance imaging; fMRI; neuroimaging
Year: 2021 PMID: 33776442 PMCID: PMC7989050 DOI: 10.2147/NDT.S307083
Source DB: PubMed Journal: Neuropsychiatr Dis Treat ISSN: 1176-6328 Impact factor: 2.570
Figure 1(A) The location of GV20 acupoint. (B) Paradigm of electro-acupuncture (EA) stimulation: the whole procedure lasted 40 min, consisting of a 15-minute acupuncture stimulation and three 5-minute MRI scans. Phase I: Preparation (before needle insertion), phase II: The first 5 minutes after initiation of EA stimulation, and Phase III: 15–20 minutes after needle removal. Needle in: The beginning of acupuncture at GV20. Needle out: needle removal.
Figure 214K gold needles (left panel) and flexible head coil (right panel).
Figure 3Comparison of ReHo values among the three phases. The red region in the figure shows significant difference in ReHo values among 3 phase, including the right posterior cingulate cortex, right calcarine gyrus, right angular gyrus, right precuneus, right cuneus, and bilateral postcentral gyri.
ReHo Regions Differences in 3 Phases
| Cluster | MNI | Mean ReHo Value ( | |||||
|---|---|---|---|---|---|---|---|
| X | Y | Z | Phase I | Phase II | Phase III | ||
| PCUN.R, extend to PCC.R | |||||||
| 182 | 3 | −42 | 27 | 29.25 | 1.585±0.055 | 1.319±0.055 | 0.991±0.055 |
| ANG.R | |||||||
| 44 | 51 | −63 | 33 | 29.06 | 1.524±0.049 | 1.310±0.049 | 0.996±0.049 |
| CAL.R, extend to CUN.R | |||||||
| 134 | 15 | −66 | 12 | 16.94 | 0.666±0.087 | 1.094±0.087 | 1.378±0.087 |
| PoCG.R | |||||||
| 63 | 45 | −18 | 57 | 14.35 | 0.226±0.087 | 0.689±0.087 | 0.864±0.087 |
| PoCG.L | |||||||
| 52 | −42 | −24 | 51 | 18.43 | 0.209±0.069 | 0.635±0.069 | 0.774±0.069 |
Notes: *Statistical significance level: first use voxel level correction, p < 0.001, then FDR clusters level correction, cluster > 39; Phase I, Preparation (before needle insertion); Phase II, during EA; Phase III, The 15 minutes after EA; X, Y, Z: coordinates of primary peak locations in the MNI space.
Abbreviations: L, left; R, right; MNI, Montreal Neurological Institute space; PCUN.R, right precuneus; PCC.R, right posterior cingulate cortex; ANG.R, right angular gyrus; CAL.R, right calcarine gyrus; CUN.R, right cuneus; PoCG.R, right postcentral gyri; PoCG.L, left postcentral gyri.
Pairwise Comparison of ReHo Values of 3 Phases
| Pairwise Comparison | Mean Difference ReHo Value | |
|---|---|---|
| PCUN.R, extend to PCC.R | ||
| Phase III < phase II | −0.327±0.078 | <0.001 |
| Phase III < phase I | −0.594±0.078 | <0.001 |
| ANG.R | ||
| Phase III < phase II | −0.313±0.078 | <0.001 |
| Phase III < phase I | −0.528±0.078 | <0.001 |
| CAL.R, extend to CUN.R | ||
| Phase II > phase I | 0.428±0.123 | 0.003 |
| Phase III > phase I | 0.712±0.123 | <0.001 |
| PoCG.R | ||
| Phase II > phase I | 0.463±0.123 | 0.001 |
| Phase III > phase I | 0.638±0.123 | <0.001 |
| PoCG.L | ||
| Phase II > phase I | 0.426±0.097 | <0.001 |
| Phase III > phase I | 0.565±0.097 | <0.001 |
Notes: Phase I, Preparation (before needle insertion); Phase II, during EA; Phase III, The 15 minutes after EA; Statistical significance level: p<0.0033 (a p < 0.05 with Bonferroni correction was adopted to correct for the number of tests); *Stands for statistically significant.
Abbreviations: L, left; R, right; PCUN.R, right precuneus; PCC.R, right posterior cingulate cortex; ANG.R, right angular gyrus; CAL.R, right calcarine gyrus; CUN.R, right cuneus; PoCG.R, right postcentral gyri; PoCG.L, left postcentral gyri.
Figure 4Pairwise comparison results of ReHo values between Phase II and Phase I. Brain regions with yellow-red colors indicate areas with a significantly increased ReHo value in Phase II compared with Phase I (a p < 0.05 with Bonferroni correction was adopted to correct for the number of tests).
Figure 5Pairwise comparison results of ReHo values between Phase III and Phase II. Brain regions with blue colors indicate areas with a significantly decreased ReHo value in Phase III compared with Phase II (a p < 0.05 with Bonferroni correction was adopted to correct for the number of tests).
Figure 6Pairwise comparison results of ReHo values between Phase III and Phase I. Brain regions with blue-green colors indicate areas with a significantly decreased ReHo value in Phase III compared with Phase I, while brain regions with yellow-red colors indicate areas a significantly increased ReHo value (a p < 0.05 with Bonferroni correction was adopted to correct for the number of tests).
The Demographic and Clinical Data of Subjects (n = 20)
| Characteristics | Frequency/Mean ± SD |
|---|---|
| Gender(male/female) | 10/10 |
| Age(year) | 26.45 ± 1.82 (22–30) |
| Education(years) | 18.63 ± 1.43 (18–21) |
| HRSD-17 | 13.10± 2.22 (10–16) |
| Soreness(VAS) | 3.70±1.56 (1–6) |
Notes: Data are expressed as the mean ± SD; Education, Transform the kind of education into the years of education; Primary school ≥ 5 years, Middle school ≥ 6 years, graduate ≥ 4 years, Postgraduate ≥5 years.
Abbreviation: HRSD-17, Hamilton Rating Scale for Depression (17 item version); VAS, Visual Analogue Scale.